Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is well-positioned for long-term growth as shown by its strong market presence with Motiva breast implants, increasing demand for its innovative products such as Preservé, and potential expansion into untapped markets such as Asia-Pacific/Middle East. Additionally, the company has exhibited strong financial performance, with positive cash flow and high revenue growth and margins. However, potential risks such as economic downturns and competition should be closely monitored.

Bears say

Establishment Labs Hldgs is expected to face headwinds in the near future due to potential funding needs, unsuccessful launch of pipeline products, and competition in the market. While the company has demonstrated strong revenue growth and has numerous market-expanding catalysts, its high valuation of 9x 12-24 month sales estimate may be unsustainable in the long term, especially if it fails to meet its free cash flow positive target in the second half of 2026. Additionally, potential risks such as an economic recession and tariffs may further hinder its growth prospects and negatively impact its financials.

ESTA has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Strong Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Strong Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.